Cargando…
(68)Ga-DOTATATE PET/CT for the detection of inflammation of large arteries: correlation with(18)F-FDG, calcium burden and risk factors
BACKGROUND: Ga-[1,4,7,10-tetraazacyclododecane-N,N′,N″,N′″-tetraacetic acid]-d-Phe(1),Tyr(3)-octreotate (DOTATATE) positron emission tomography (PET) is commonly used for the visualization of somatostatin receptor (SSTR)-positive neuroendocrine tumors. SSTR is also known to be expressed on macrophag...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3475087/ https://www.ncbi.nlm.nih.gov/pubmed/23016793 http://dx.doi.org/10.1186/2191-219X-2-52 |
Sumario: | BACKGROUND: Ga-[1,4,7,10-tetraazacyclododecane-N,N′,N″,N′″-tetraacetic acid]-d-Phe(1),Tyr(3)-octreotate (DOTATATE) positron emission tomography (PET) is commonly used for the visualization of somatostatin receptor (SSTR)-positive neuroendocrine tumors. SSTR is also known to be expressed on macrophages, which play a major role in inflammatory processes in the walls of coronary arteries and large vessels. Therefore, imaging SSTR expression has the potential to visualize vulnerable plaques. We assessed (68)Ga-DOTATATE accumulation in large vessels in comparison to (18)F-2-fluorodeoxyglucose (FDG) uptake, calcified plaques (CPs), and cardiovascular risk factors. METHODS: Sixteen consecutive patients with neuroendocrine tumors or thyroid cancer underwent both (68)Ga-DOTATATE and (18)F-FDG PET/CT for staging or restaging purposes. Detailed clinical data, including common cardiovascular risk factors, were recorded. For a separate assessment, they were divided into a high-risk and a low-risk group. In each patient, we calculated the maximum target-to-background ratio (TBR) of eight arterial segments. The correlation of the TBR(mean) of both tracers with risk factors including plaque burden was assessed. RESULTS: The mean TBR of (68)Ga-DOTATATE in all large arteries correlated significantly with the presence of CPs (r = 0.52; p < 0.05), hypertension (r = 0.60; p < 0.05), age (r = 0.56; p < 0.05), and uptake of (18)F-FDG (r = 0.64; p < 0.01). There was one significant correlation between (18)F-FDG uptake and hypertension (0.58; p < 0.05). Out of the 37 sites with the highest focal (68)Ga-DOTATATE uptake, 16 (43.2%) also had focal (18)F-FDG uptake. Of 39 sites with the highest (18)F-FDG uptake, only 11 (28.2%) had a colocalized (68)Ga-DOTATATE accumulation. CONCLUSIONS: In this series of cancer patients, we found a stronger association of increased (68)Ga-DOTATATE uptake with known risk factors of cardiovascular disease as compared to (18)F-FDG, suggesting a potential role for plaque imaging in large arteries. Strikingly, we found that focal uptake of (68)Ga-DOTATATE and (18)F-FDG does not colocalize in a significant number of lesions. |
---|